CMS Open Payments · Program Year 2024
Sequoia Surgical Distributors, LLC
Sequoia Surgical Distributors, LLC reported $427,602.52 across General Payments, Research, and Ownership to 16 physicians and teaching hospitals across 28 transactions.
- $427.6K Above-median payer
- All-tracks total
- 28 Below-median volume
- Transactions
- 16 Below-median reach
- Recipients
- −$5.2K
- General Payments vs PY2023
Sequoia Surgical Distributors, LLC reported $427,602.52 across all CMS Open Payments tracks (General + Research + Ownership) to 16 physicians and teaching hospitals in Program Year 2024 - ranking #802 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $65,838.00, averaging $26.7K per recipient.
How Sequoia Surgical Distributors, LLC's $427.6K all-tracks total breaks down
Sequoia Surgical Distributors, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
14/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer sequoia-surgical-distributors-llc Sequoia Surgical Distributors, LLC
$427.6K · #802/1,925 · 0.0% industry · PY2024
- TOT $427.6K
- RANK #802
- SHARE 0.0%
- TXN 28
- RCP 16
- CAT 2
- GEN $65.8K
- ΔGEN −$5.2K
- TOP1 92.3%
- PY 2024
Volume peers
Nearest volume peer: Cepheid ($423.4K)
Sequoia Surgical Distributors, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Sequoia Surgical Distributors, LLC's CMS-reported General Payments decreased by $5.2K (−7.3%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SEQUOIA SURGICAL DISTRIBUTORS, LLCPY2023: SEQUOIA SURGICAL DISTRIBUTORS, LLCPY2024: Sequoia Surgical Distributors, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $71,050.00
- PY2024
- $65,838.00
What the Data Shows for Sequoia Surgical Distributors, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Sequoia Surgical Distributors, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 2 general-payment categories charted below, "Acquisitions" is the largest at $60.8K across 4 transactions, 92.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 2 types of general payments, Sequoia Surgical Distributors, LLC's largest category was "Acquisitions" at $60.8K - 92.3% of General Payments.
How Sequoia Surgical Distributors, LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Acquisitions | $60.8K | 4 | 92.3% |
| Compensation for Services Other Than Consulting | $5.1K | 12 | 7.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $65,838.00 (100.0%) of $65,838.00 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Sequoia Surgical Distributors, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Burton Redd
$60,750.00 across 4 reported transactions
- 2
Frank Feng
$5,088.00 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Sequoia Surgical Distributors, LLC ranks #802 of 1,925 by total payments (top 42% by spend) but is notably more concentrated than that alone would suggest -- #188 of 1,838 by HHI (top 10% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Jubilant DraxImage Inc. : $17.7K total payments, HHI 8710
- Elucid Bioimaging Inc : $130.1K total payments, HHI 8681
- Biolase MG LLC : $11.5K total payments, HHI 8681
- Xiros Inc : $3.4K total payments, HHI 8644
- Emmaus Medical, Inc. : $197.9K total payments, HHI 8631
- OrthoPediatrics Canada ULC : $104.0K total payments, HHI 8624
- Sequoia Surgical Distributors, LLC (this company) : $65.8K total payments, HHI 8574
- Auxano Medical LLC : $8.8K total payments, HHI 8543
- Swan Valley Medical Incorporated : $65.3K total payments, HHI 8507
- Veryan Medical Incorporated : $359.2K total payments, HHI 8362
- Poriferous LLC : $7.6K total payments, HHI 8281
- Myocardial Solutions, Inc. : $4.2K total payments, HHI 8121
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Sequoia Surgical Distributors, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Sequoia Surgical Distributors, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Sequoia Surgical Distributors, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Almatica Pharma LLC
Rayner Intraocular Lenses Limited
Bio-Rad Laboratories, Inc.
Spectrum Pharmaceuticals Inc.
NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd.
Put this to use
Sequoia Surgical Distributors, LLC ranks #802 of 1,925 by all-tracks total payments, led by "Acquisitions".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Acquisitions" spend across every manufacturer, not just Sequoia Surgical Distributors, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.